On September 14, 2023, Dr. Jonathan Milner announced that he has decided to vote against the proposed acquisition of Abcam plc by Danaher Corporation and he will formally request the Company?s board of directors to convene a general meeting to replace the Company?s board, including the current CEO, CFO and Chairman. In addition, Jonathan Milner stated that his decision to oppose the acquisition has received feedback from shareholders and analysts, who share his belief that the $24 per share offer announced on 28 August 2023 by the Company substantially undervalues Abcam and considering the potential of the Company as an independent entity with an effective board and executive leadership, the proposed acquisition price falls significantly short of its inherent worth.